Home>Cyclodextrin MOFs modified dry powder inhalers quadruple bioavailability of luteolin to ameliorate fibrosing interstitial lung disease
Cyclodextrin MOFs modified dry powder inhalers quadruple bioavailability of luteolin to ameliorate fibrosing interstitial lung disease
- Impact factors: 5.8
- Publication: INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Author:Xiaohong Ren, Ting Yang, Kaikai Zhang, Yujie Liu, Caifen Wang, Li Wu, Jiwen Zhang
- DOI citation-doi:10.1016/j.ijpharm.2023.123405
- Date:2023-09-11